D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 91 Citations 42,218 346 World Ranking 7197 National Ranking 248

Overview

What is he best known for?

The fields of study Harry Bartelink is best known for:

  • Cancer
  • Statistics
  • Chemotherapy

Harry Bartelink combines Internal medicine and Gastroenterology in his studies. Gastroenterology and Internal medicine are two areas of study in which Harry Bartelink engages in interdisciplinary work. Surgery is closely attributed to Head and neck in his research. He connects Cancer with Lymph node in his research. Harry Bartelink merges Radiation therapy with Chemotherapy in his research. Harry Bartelink brings together Chemotherapy and Cancer to produce work in his papers. While working in this field, Harry Bartelink studies both Breast cancer and Mastectomy. His multidisciplinary approach integrates Mastectomy and Breast cancer in his work. Harry Bartelink merges Multivariate analysis with Univariate analysis in his study.

His most cited work include:

  • Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. (1117 citations)
  • Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer (771 citations)
  • Prognostic factors of neck node metastasis (428 citations)

What are the main themes of his work throughout his whole career to date

His Internal medicine study frequently links to other fields, such as Randomized controlled trial. His study deals with a combination of Randomized controlled trial and Cancer. Harry Bartelink carries out multidisciplinary research, doing studies in Cancer and Clinical trial. In his research, Harry Bartelink undertakes multidisciplinary study on Surgery and Radiology. By researching both Radiology and Internal medicine, he produces research that crosses academic boundaries. Harry Bartelink combines Oncology and Chemotherapy in his research. Harry Bartelink performs integrative study on Chemotherapy and Cisplatin in his works. He brings together Breast cancer and Mastectomy to produce work in his papers. Harry Bartelink conducted interdisciplinary study in his works that combined Mastectomy and Breast cancer.

Harry Bartelink most often published in these fields:

  • Internal medicine (83.52%)
  • Radiation therapy (60.44%)
  • Cancer (57.14%)

What were the highlights of his more recent work (between 2008-2016)?

  • Internal medicine (100.00%)
  • Cancer (100.00%)
  • Breast cancer (90.00%)

In recent works Harry Bartelink was focusing on the following fields of study:

His work on Internal medicine is being expanded to include thematically relevant topics such as Proportional hazards model. In his works, he undertakes multidisciplinary study on Cancer and Clinical endpoint. Breast cancer and Systemic therapy are commonly linked in his work. While working in this field, Harry Bartelink studies both Oncology and Gynecology. Harry Bartelink undertakes multidisciplinary investigations into Gynecology and Oncology in his work. His study deals with a combination of Paleontology and Stage (stratigraphy). He performs multidisciplinary studies into Stage (stratigraphy) and Paleontology in his work. Harry Bartelink integrates many fields in his works, including Mastectomy and Breast-conserving surgery. He carries out multidisciplinary research, doing studies in Breast-conserving surgery and Mastectomy.

Between 2008 and 2016, his most popular works were:

  • Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer (771 citations)
  • The impact of preoperative MRI on breast-conserving surgery of invasive cancer: a comparative cohort study (114 citations)
  • Long-term cosmetic changes after breast-conserving treatment of patients with stage I–II breast cancer and included in the EORTC ‘boost versus no boost’ trial (65 citations)

In his most recent research, the most cited works focused on:

  • Cancer
  • Mammography
  • Surgery

Many of his studies on Internal medicine involve topics that are commonly interrelated, such as Cohort. His Cohort study often links to related topics such as Internal medicine. Harry Bartelink connects Cancer with Ductal carcinoma in his study. His study deals with a combination of Ductal carcinoma and Cancer. In his articles, he combines various disciplines, including Mastectomy and Breast-conserving surgery. Harry Bartelink integrates Breast-conserving surgery with Mastectomy in his study. Many of his studies involve connections with topics such as Thoracic wall and Surgery. Harry Bartelink regularly ties together related areas like Surgery in his Thoracic wall studies. His Breast cancer study frequently draws connections to other fields, such as Supraclavicular lymph nodes.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

A Gene-Expression Signature as a Predictor of Survival in Breast Cancer

Marc J. van de Vijver;Yudong D. He;Laura J. van 't Veer;Hongyue Dai.
The New England Journal of Medicine (2002)

7499 Citations

Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups.

H Bartelink;F Roelofsen;F Eschwege;P Rougier.
Journal of Clinical Oncology (1997)

1576 Citations

Long-Term Results of a Randomized Trial Comparing Breast-Conserving Therapy With Mastectomy: European Organization for Research and Treatment of Cancer 10801 Trial

Joop A. van Dongen;Adri C. Voogd;Ian S. Fentiman;Catherine Legrand.
Journal of the National Cancer Institute (2000)

1573 Citations

Impact of a Higher Radiation Dose on Local Control and Survival in Breast-Conserving Therapy of Early Breast Cancer: 10-Year Results of the Randomized Boost Versus No Boost EORTC 22881-10882 Trial

Harry Bartelink;Jean-Claude Horiot;Philip M. Poortmans;Henk Struikmans.
Journal of Clinical Oncology (2007)

1335 Citations

Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival

Howard Y. Chang;Dimitry S. A. Nuyten;Julie B. Sneddon;Trevor Hastie.
Proceedings of the National Academy of Sciences of the United States of America (2005)

1166 Citations

Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation.

Harry Bartelink;Jean-Claude Horiot;Philip Poortmans;Henk Struikmans.
The New England Journal of Medicine (2001)

1132 Citations

Long-Term Cause-Specific Mortality of Patients Treated for Hodgkin’s Disease

Berthe M.P. Aleman;Alexandra W. van den Belt-Dusebout;Willem J. Klokman;Mars B. van’t Veer.
Journal of Clinical Oncology (2003)

905 Citations

Long-term risk of cardiovascular disease in 10-year survivors of breast cancer.

Maartje J. Hooning;Akke Botma;Berthe M. P. Aleman;Margreet H. A. Baaijens.
Journal of the National Cancer Institute (2007)

897 Citations

Internal mammary and medial supraclavicular irradiation in breast cancer

P.M.P. Poortmans;S. Collette;C. Kirkove;E. van Limbergen.
The New England Journal of Medicine (2015)

890 Citations

Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas.

Bas Kreike;Marieke van Kouwenhove;Hugo M Horlings;Britta Weigelt.
Breast Cancer Research (2007)

780 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Harry Bartelink

Monica Morrow

Monica Morrow

Memorial Sloan Kettering Cancer Center

Publications: 113

Frank A. Vicini

Frank A. Vicini

Beaumont Health

Publications: 91

Bruce G. Haffty

Bruce G. Haffty

Rutgers, The State University of New Jersey

Publications: 84

Roberto Orecchia

Roberto Orecchia

European Institute of Oncology

Publications: 81

Alain Fourquet

Alain Fourquet

Institute Curie

Publications: 75

Emiel J. Th. Rutgers

Emiel J. Th. Rutgers

Antoni van Leeuwenhoek Hospital

Publications: 74

Ian O. Ellis

Ian O. Ellis

University of Nottingham

Publications: 69

Marc J. van de Vijver

Marc J. van de Vijver

University of Amsterdam

Publications: 66

Frederik Wenz

Frederik Wenz

Heidelberg University

Publications: 65

Laura J. van't Veer

Laura J. van't Veer

University of California, San Francisco

Publications: 65

Jorge S. Reis-Filho

Jorge S. Reis-Filho

Memorial Sloan Kettering Cancer Center

Publications: 65

Christos Sotiriou

Christos Sotiriou

Université Libre de Bruxelles

Publications: 65

Marcel van Herk

Marcel van Herk

University of Manchester

Publications: 64

Jens Overgaard

Jens Overgaard

Aarhus University Hospital

Publications: 63

Giuseppe Viale

Giuseppe Viale

University of Milan

Publications: 59

Jay R. Harris

Jay R. Harris

Brigham and Women's Hospital

Publications: 58

Trending Scientists

Boris Aronov

Boris Aronov

New York University

Wonnop Visessanguan

Wonnop Visessanguan

National Center for Genetic Engineering and Biotechnology

Yoshiki Chujo

Yoshiki Chujo

Kyoto University

Heon Lee

Heon Lee

Korea University

Marcel Honza

Marcel Honza

Czech Academy of Sciences

Uwe Zangemeister-Wittke

Uwe Zangemeister-Wittke

University of Bern

Tulasi Satyanarayana

Tulasi Satyanarayana

University of Delhi

Bernd Timmermann

Bernd Timmermann

Max Planck Society

Ping Wu

Ping Wu

Zhejiang University

Jerald R. Ziemke

Jerald R. Ziemke

Goddard Space Flight Center

Peter John Huybers

Peter John Huybers

Harvard University

Lars Holmberg

Lars Holmberg

King's College London

Evan A. Stein

Evan A. Stein

Medpace (United States)

Sidney Bloch

Sidney Bloch

University of Melbourne

Ruth Parslow

Ruth Parslow

University of Melbourne

Andrew J. Hill

Andrew J. Hill

University of Leeds

Something went wrong. Please try again later.